Lachesis Mutus
Generic Name: lachesis mutus
Brand Names:
Lachesis Mutus 7124
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS Use according to standard homeopathic indications for self-limiting conditions. Common Materia Medica indications: menstrual problems, hot flashes, cramps, varicose veins, sore throat.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Lachesis Mutus used for?▼
INDICATIONS Use according to standard homeopathic indications for self-limiting conditions. Common Materia Medica indications: menstrual problems, hot flashes, cramps, varicose veins, sore throat.*
Can I take Lachesis Mutus during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Lachesis Mutus?▼
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Lidocaine 4% With Menthol 1%
lidocaine 4% with menthol 1%
Amide Local Anesthetic [EPC]
Purpose Topical anesthetic
Tebentafusp
tebentafusp
Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]
11 DESCRIPTION Tebentafusp-tebn is a bispecific gp100 peptide-HLA-directed T cell receptor CD3 T cell engager. Tebentafusp-tebn has an approximate molecular weight of 77 kDa. Tebentafusp-tebn is produced by recombinant DNA technology in Escherichia coli cells. KIMMTRAK (tebentafusp-tebn) injection is supplied in a single-dose vial as a sterile, preservative-free, clear, colorless or slightly yellowish solution for intravenous administration by infusion.
Avobenzone 3%, Homosalate 10%, Octisalate 5% ,octocrylene 8%
avobenzone 3%, homosalate 10%, octisalate 5% ,octocrylene 8%
SUNSCREEN
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.